Evidence map›Paper›PMID 35645615›Full record

ArticleGenetics research2022

An Independent Prognostic Model Based on Ten Autophagy-Related Long Noncoding RNAs in Pancreatic Cancer Patients.

Jiahui Tian, Chunyan Fu, Xuan Zeng, Xiaoxiao Fan, Yi Wu

Abstract read
In one paragraph

Article in Genetics research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Autophagy-Related ncRNAs in Pancreatic Cancer.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiahui TianDepartment of Laboratory, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, China.ORCID 0000-0003-1494-3061
Chunyan FuDepartment of Medicine, Hunan Normal University, Changsha, Hunan 410005, China.
Xuan ZengDepartment of Medicine, Hunan Normal University, Changsha, Hunan 410005, China.
Xiaoxiao FanDepartment of Laboratory, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, China.
Yi WuDepartment of Laboratory, The First Affiliated Hospital of Hunan Normal University, Changsha, Hunan 410005, China.ORCID 0000-0003-4527-4120

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Pancreatic cancer (PC) is a common, highly lethal cancer with a low survival rate. Autophagy is involved in the occurrence and progression of PC. This study aims to explore the feasibility of using an autophagy-related long noncoding RNA (lncRNA) signature for assessing PC patient survival. Methods: We obtained RNA sequencing and clinical data of patients from the TCGA website. Autophagy genes were obtained from the Human Autophagy Database. The prognostic model, generated through univariate and multivariate Cox regression analyses, included 10 autophagy-related lncRNAs. Receiver operating characteristic (ROC) curves and forest plots were generated for univariate and multivariate Cox regression analyses, to examine the predictive feasibility of the risk model. Gene set enrichment analysis (GSEA) was used to screen enriched gene sets. Results: Twenty-eight autophagy-related lncRNAs were filtered out through univariate Cox regression analysis ( Conclusion: A signature based on ten autophagy-related lncRNAs was identified. This signature could be potentially used for evaluating clinical prognosis and might be used for targeted therapy against PC.

Indexed as

Pancreatic NeoplasmsRNA, Long NoncodingAutophagyGene Expression Regulation, NeoplasticHumansPrognosisRNA, Long Noncoding

Identifiers

PMID35645615
PMCPMC9124146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.